Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis-Reference-Cited by-同舟云学术

Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis

Published:2021-06 Issue: Volume:236 Page:59-68
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Akao Masaharu,Yasuda Satoshi,Kaikita Koichi,Ako Junya,Matoba Tetsuya,Nakamura Masato,Miyauchi Katsumi,Hagiwara Nobuhisa,Kimura Kazuo,Hirayama Atsushi,Matsui Kunihiko,Ogawa Hisao

Funder

Bayer Healthcare

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Antithrombotic therapy for atrial fibrillation with stable coronary disease;Yasuda;N Engl J Med,2019

2. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation;Gage;JAMA,2001

3. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation;Lip;Chest,2010

4. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey;Pisters;Chest,2010

5. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS);Hindricks;Eur Heart J,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20

2. Assessing the Safety and Efficacy of Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation: A Systemic Review and Meta-Analysis;Cureus;2024-02-15

3. Efficacy and Safety of Different Dosing Regimens of Rivaroxaban in Patients With Atrial Fibrillation for Stroke Prevention: A Systematic Review and Meta-Analysis;Cureus;2024-01-02

4. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study;Cardiology Journal;2022-12-13

5. Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges;Journal of Neurology, Neurosurgery & Psychiatry;2022-06-21